Boards & Committees - Board of Directors




PAST MEETINGS:
Tuesday, April 4, 2017, 8:00 AM - 2:00 PM
in City View AB of the Manchester Grand Hyatt Hotel, San Diego, CA, USA, during the ISHLT 37th Annual Meeting and Scientific Sessions

Saturday, April 8, 2017, 12:00 PM - 6:00 PM
in City View AB of the Manchester Grand Hyatt Hotel, San Diego, CA, USA, during the ISHLT 37th Annual Meeting and Scientific Sessions



ABOUT THE BOARD OF DIRECTORS

The ISHLT Board of Directors is comprised of 15 individuals: the four Officers (Past President, President, President-Elect, and Secretary-Treasurer) and eleven Directors, reflecting the geographic and disciplinary constituencies of the Society.

The Editor of the Journal of Heart and Lung Transplantion, the Medical Director of the Registry, the Annual Meeting Scientific Program Chair, the Chair of the Development Committee, and the Executive Director serve as ex-officio, non-voting members of the Board.

BOARD OF DIRECTORS
(Parentheses after name indicates year rotating off Board)



EXECUTIVE OFFICERS:


PRESIDENT
Andrew J. Fisher, FRCP, PhD (2019)
Freeman Hospital
Newcastle Upon Tyne, UK
44-191-233-6161
a.j.fisher@ncl.ac.uk

Andrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as an Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.



PRESIDENT-ELECT
Jeffrey J. Teuteberg, MD (2020)
University of Pittsburgh/Presbyterian
Pittsburgh, Pennsylvania, USA
412-647-7168
teutebergjj@upmc.edu

Jeffrey Teuteberg, MD, is an Assistant Professor of Medicine, Associate Director of the Cardiac Transplant Program, and a member of the Heart Failure/Cardiac Transplant section of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Medical Center, where he specializes in the care of patients with advanced cardiomyopathies, cardiac transplantation, ventricular assist devices and pulmonary hypertension. He has particular interests in advanced heart failure and the transition to cardiac transplantation and ventricular assist devices. Dr. Teuteberg graduated from the University of Chicago, Pritzker School of Medicine, in 1992 and remained at the University of Chicago for his Internal Medicine Residency and general Cardiovascular Fellowship, during which he spent a year as the Chief Medical Resident. Dr. Teuteberg received his Heart Failure and Cardiac Transplant training at Brigham and Women's hospital in Boston.



PAST PRESIDENT
Maryl R. Johnson, MD (2018)
University of Wisconsin
Madison, WI, USA
608-263-0080
mrj@medicine.wisc.edu

Maryl R. Johnson, MD, received her medical degree from the University of Iowa College of Medicine where she also completed postgraduate training in Internal Medicine and Cardiovascular Diseases. She joined the faculty at Iowa and was instrumental in the establishment of a cardiac transplant program, serving as the Medical Director of Cardiac Transplantation from 1984-1988. Her subsequent career has been entirely devoted to the care of patients with heart failure and following cardiac transplantation. She served as the Associate Medical Director of the Cardiac Transplant Program at Loyola University Medical Center from 1988-1994, Associate Medical Director of the Rush Heart Failure and Cardiac Transplant Program from 1994-1997, and Medical Director, Heart Failure and Transplantation at Northwestern Memorial Hospital from 1998-2002. She moved to the University of Wisconsin as Medical Director of Heart Failure and Transplantation and Professor of Medicine in July 2002. Dr. Johnson's clinical interests are in the care of patients with severe congestive heart failure, including the use of mechanical circulatory support devices and cardiac transplantation. She has a particular interest in the treatment and outcome of congestive heart failure in women. Her research interests include the use of mechanical assistance in patients with severe heart failure and the coronary artery disease which develops in cardiac transplant recipients. She has also been an investigator in many of the multicenter trials evaluating new agents for the medical treatment of heart failure.



TREASURER
Joseph Rogers, MD (2018)
Duke University Medical Center
Durham, NC, USA
joseph.rogers@duke.edu

Bio coming soon...



SECRETARY
Lara Danziger-Isakov, MD, MPH (2018)
Children's Hospital Medical Center
Cincinnati, OH, USA
lara.danziger-isakov@cchmc.org

Lara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is the Director of Pediatric Immunocompromised Host Infectious Diseases and Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and complete her residency in Pediatrics at the Cleveland Clinic. She also completed a fellowship in Pediatric Infectious Diseases at St. Louis Children's Hospital and Washington University. Dr. Danziger-Isakov is board-certified in Pediatrics and Pediatric Infectious Diseases by the American Board of Pediatrics. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on pediatric and adult lung transplantation. In addition, Dr. Danziger-Isakov participates in clinical trials to evaluate new infectious disease therapies, new methods of detection for infectious diseases, and vaccination in immunocompromised hosts.



DIRECTORS:


Kevin Chan, MD (2020)
University of Michigan Health System
Ann Arbor, MI, USA
kevichan@umich.edu

Bio coming soon...



Jason D. Christie, MD (2019)
University of Pennsylvania
Philadelphia, PA, USA
215-573-3209
jchristi@mail.med.upenn.edu

Jason D. Christie, M.D., M.S. is the Chief of the Pulmonary, Allergy, and Critical Care Division. He is Professor of Medicine in the Department of Medicine and Professor of Epidemiology in the Department of Biostatistics and Epidemiology at the University of Pennsylvania. He is a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics. His career is focused on translational research studies of the risks, pathogenesis, treatment, and outcomes of acute lung injury (ALI) in the transplant and non-transplant human populations. Through leadership of the Center for Translational Lung Biology, Dr. Christie brings together clinicians, bench scientists, epidemiologists, and statisticians to build multidisciplinary research teams. His research integrates new knowledge generated from bench studies with epidemiology approaches in well-phenotyped, large human populations to generate new definitions of human syndromes, improved diagnostics and prognostics, and targeted therapy approaches in advanced lung diseases and critical illness.

Dr. Christie is the founder of the lung transplant outcomes group (LTOG), which is a multicentered cohort study the etiology and pathogenesis of acute lung injury following lung transplantation (termed primary graft dysfunction). This line of research is funded by multiple R01 grants from NHLBI; active LTOG research themes focus on the mechanisms of clinical factors that elevate PGD risk, including donor smoke exposure, recipient obesity and body composition, pulmonary hypertension, alterations in lung microbiome, and autoimmunity to lung collagens. His multidisciplinary lung transplant research focuses on genetics, innate immunity, regulatory T-cells, innate lymphoid cell (ILC) populations in the lung, ischemia reperfusion injury, inflammation, and autoimmunity.




Jennifer Cowger, MD, MS (2020)
St. Vincent's Heart Center of Indiana
Indianapolis, IN, USA
734-546-4911
Jennifercowger@gmail.com

Dr. Jennifer Cowger is the medical director of the Henry Ford Mechanical Circulatory Support Program in Detroit, Michigan. She has a masters in biostatistics & clinical trial design from the University of Michigan and is the chair of the IMACS research committee and is on the DAAP Committee of INTERMACS. She joined the ISHLT board of directors in 2017 and is a liaison for the Education committee.



Teresa De Marco, MD, FACC (2020)
University of California, San Francisco
San Francisco, California, USA
415-476-3117
demarco@medicine.ucsf.edu

Bio coming soon...



Tobias Deuse, MD, PhD (2018)
University of California - San Francisco
San Francisco, CA, USA
Tobias.Deuse@ucsf.edu

Tobias Deuse is Transplant and MCS Surgeon at the University of California San Francisco. He completed his cardiothoracic residency in Munich and Hamburg, and completed a fellowship in Thoracic Transplantation and Mechanical Circulatory Support at Stanford University. His main clinical interests are minimally-invasive lung transplantation and minimally-invasive LVAD implantation. His research focus includes the development of new immunosuppressive/ immunomodulatory agents and alternative forms of administration like inhaled immunosuppression or cell-based immunomodulation. He is also active in the field of pluripotent stem cell research and tissue regeneration.



Howard J. Eisen, MD (2019)
Drexel University College of Medicine
Philadelphia, PA, USA
heisen@drexelmed.edu

Bio coming soon...



Stephan M. Ensminger, MD, DPhil (2020)
Heart and Diabetes Center NRW
Ruhr-University Bochum
Bad Oeynhausen, GERMANY
05731 / 97 1331
sensminger@hdz-nrw.de

Bio coming soon...



Daniel J. Goldstein, MD (2018)
Montefiore Medical Center
Bronx, New York, USA
718-920-2144
dgoldste@montefiore.org

Dr. Daniel J. Goldstein is a Professor at the Albert Einstein College of Medicine and Vice Chairman of the Department of Cardiothoracic Surgery at Montefiore Medical Center in New York where he also serves as the Director of the Mechanical Assistance Program. He is a graduate of the Mount Sinai School of Medicine (1991) and completed his general surgery and cardiothoracic surgery training at Columbia Presbyterian Medical Center in New York in 2000. While clinically active in all aspects of adult cardiothoracic surgery including coronary, valvular and aneurysmal heart disease, his clinical and research interests focus on the surgical management of end stage heart disease including stem cell therapies and pharmacological adjuncts for induction of left ventricular recovery in patients supported with left ventricular assist devices. Dr. Goldstein is an active member of the INTERMACS adverse event committee and has partaken as principal site investigator in multiple industry-based and NIH-supported clinical ventricular assist device trials.



Peter M. Hopkins, FRACP (2018)
The Prince Charles Hospital
Brisbane, AUSTRALIA
61-7-3350-8111
Peter_Hopkins@health.qld.gov.au

Dr Peter Hopkins is the Director of the Queensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. Executive positions are held with the Australian Lung Foundation (PIVOT and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and National Examiners Panel Royal Australian College of Physicians.



Michael G. Petty, PhD, RN, CNS (2018)
University of Minnesota Medical Center
Minneapolis, MN, USA
612-273-5607
mpetty1@fairview.org

Dr. Michael Petty is the Cardiothoracic Clinical Nurse Specialist at the University of Minnesota Medical Center, Minneapolis, MN.  He received his initial nursing degree from St. Mary’s Junior College, Minneapolis, MN, and subsequently obtained a Bachelors Degree in Nursing from the University of the State of New York, and a Masters Degree and PhD in Nursing from the University of Minnesota.  He began his career as a staff nurse in the Surgical ICU at the University of Minnesota Hospital and Clinic, and has held a variety of clinical, administrative, and industry roles in the subsequent years.  Much of his focus and interest during that time has been in the care of patients with cardiovascular disorders requiring medical, surgical, and transplant interventions. He has been an active participant in the Mechanical Circulatory Support community since 1995 including serving as president of the International Consortium of Circulatory Assist Clinicians (ICCAC) in 2013.  His clinical research interests focus on thoracic transplant and family caregivers of MCS patients.



Dirk Van Raemdonck, MD, PhD (2019)
University Hospital Gasthuisberg
Leuven, Belgium
32-16-34-68-23
dirk.vanraemdonck@uz.kuleuven.ac.be

Bio coming soon...



EX-OFFICIO BOARD MEMBERS:

EXECUTIVE DIRECTOR
Amanda W. Rowe (1992 - Present)
ISHLT
14673 Midway Rd., Suite 200
Addison, Texas, 75001
972-490-9495
amanda.rowe@ishlt.org

Bio coming soon...



2017-2018 ISHLT Board of Directors

Members of the 2017-2018 ISHLT Board of Directors convened in April 2017 at the ISHLT Annual Meeting in San Diego, CA.




BOARD OF DIRECTORS
(Parentheses after name indicates year rotating off Board)


EXECUTIVE OFFICERS:

PRESIDENT
Andrew J. Fisher, FRCP, PhD (2019)
Freeman Hospital
Newcastle Upon Tyne, UK
44-191-233-6161
a.j.fisher@ncl.ac.uk

Andrew Fisher is Academic Director and Honorary Consultant Respiratory and Transplant Physician at the Institute of Transplantation, Freeman Hospital, Newcastle Upon Tyne and Professor of Respiratory Transplant Medicine at Newcastle University Medical School. He graduated from Nottingham University in 1993 and received research training as an Medical Research Council training fellow in Newcastle and Edinburgh 1996-99. He was subsequently awarded a GlaxoSmithKline Senior Clinical Research Fellowship 2005-2010. He has previously served as Chair of the British Thoracic Society Science and Research Committee 2009-2012 and Chair of the European Respiratory Society Lung Transplant Group 2010-2013.


PRESIDENT-ELECT
Jeffrey J. Teuteberg, MD (2020)
University of Pittsburgh/Presbyterian
Pittsburgh, Pennsylvania, USA
412-647-7168
teutebergjj@upmc.edu

Jeffrey Teuteberg, MD, is an Assistant Professor of Medicine, Associate Director of the Cardiac Transplant Program, and a member of the Heart Failure/Cardiac Transplant section of the McGowan Institute for Regenerative Medicine at the University of Pittsburgh Medical Center, where he specializes in the care of patients with advanced cardiomyopathies, cardiac transplantation, ventricular assist devices and pulmonary hypertension. He has particular interests in advanced heart failure and the transition to cardiac transplantation and ventricular assist devices. Dr. Teuteberg graduated from the University of Chicago, Pritzker School of Medicine, in 1992 and remained at the University of Chicago for his Internal Medicine Residency and general Cardiovascular Fellowship, during which he spent a year as the Chief Medical Resident. Dr. Teuteberg received his Heart Failure and Cardiac Transplant training at Brigham and Women's hospital in Boston.


PAST PRESIDENT
Maryl R. Johnson, MD (2018)
University of Wisconsin
Madison, WI, USA
608-263-0080
mrj@medicine.wisc.edu

Maryl R. Johnson, MD, received her medical degree from the University of Iowa College of Medicine where she also completed postgraduate training in Internal Medicine and Cardiovascular Diseases. She joined the faculty at Iowa and was instrumental in the establishment of a cardiac transplant program, serving as the Medical Director of Cardiac Transplantation from 1984-1988. Her subsequent career has been entirely devoted to the care of patients with heart failure and following cardiac transplantation. She served as the Associate Medical Director of the Cardiac Transplant Program at Loyola University Medical Center from 1988-1994, Associate Medical Director of the Rush Heart Failure and Cardiac Transplant Program from 1994-1997, and Medical Director, Heart Failure and Transplantation at Northwestern Memorial Hospital from 1998-2002. She moved to the University of Wisconsin as Medical Director of Heart Failure and Transplantation and Professor of Medicine in July 2002. Dr. Johnson's clinical interests are in the care of patients with severe congestive heart failure, including the use of mechanical circulatory support devices and cardiac transplantation. She has a particular interest in the treatment and outcome of congestive heart failure in women. Her research interests include the use of mechanical assistance in patients with severe heart failure and the coronary artery disease which develops in cardiac transplant recipients. She has also been an investigator in many of the multicenter trials evaluating new agents for the medical treatment of heart failure.


TREASURER
Joseph Rogers, MD (2018)
Duke University Medical Center
Durham, NC, USA
joseph.rogers@duke.edu

Bio coming soon...

SECRETARY
Lara Danziger-Isakov, MD, MPH (2018)
Children's Hospital Medical Center
Cincinnati, OH, USA
lara.danziger-isakov@cchmc.org

Lara Danziger-Isakov, MD, MPH, practices pediatric infectious diseases at Cincinnati Children's Hospital Medical Center where she is the Director of Pediatric Immunocompromised Host Infectious Diseases and Professor of Pediatrics at the University of Cincinnati. Dr. Danziger-Isakov earned her MD at Case Western Reserve University School of Medicine and complete her residency in Pediatrics at the Cleveland Clinic. She also completed a fellowship in Pediatric Infectious Diseases at St. Louis Children's Hospital and Washington University. Dr. Danziger-Isakov is board-certified in Pediatrics and Pediatric Infectious Diseases by the American Board of Pediatrics. Her clinical interests include pediatric infectious diseases, infections in transplant recipients, and infections in immunocompromised patients. Her research interests include outcomes related to infection after pediatric transplantation with an emphasis on pediatric and adult lung transplantation. In addition, Dr. Danziger-Isakov participates in clinical trials to evaluate new infectious disease therapies, new methods of detection for infectious diseases, and vaccination in immunocompromised hosts.


DIRECTORS:


Kevin Chan, MD (2020)
University of Michigan Health System
Ann Arbor, MI, USA
kevichan@umich.edu

Bio coming soon...

Jason D. Christie, MD (2019)
University of Pennsylvania
Philadelphia, PA, USA
215-573-3209
jchristi@mail.med.upenn.edu

Jason D. Christie, M.D., M.S. is the Chief of the Pulmonary, Allergy, and Critical Care Division. He is Professor of Medicine in the Department of Medicine and Professor of Epidemiology in the Department of Biostatistics and Epidemiology at the University of Pennsylvania. He is a Senior Scholar in the Center for Clinical Epidemiology and Biostatistics. His career is focused on translational research studies of the risks, pathogenesis, treatment, and outcomes of acute lung injury (ALI) in the transplant and non-transplant human populations. Through leadership of the Center for Translational Lung Biology, Dr. Christie brings together clinicians, bench scientists, epidemiologists, and statisticians to build multidisciplinary research teams. His research integrates new knowledge generated from bench studies with epidemiology approaches in well-phenotyped, large human populations to generate new definitions of human syndromes, improved diagnostics and prognostics, and targeted therapy approaches in advanced lung diseases and critical illness.

Dr. Christie is the founder of the lung transplant outcomes group (LTOG), which is a multicentered cohort study the etiology and pathogenesis of acute lung injury following lung transplantation (termed primary graft dysfunction). This line of research is funded by multiple R01 grants from NHLBI; active LTOG research themes focus on the mechanisms of clinical factors that elevate PGD risk, including donor smoke exposure, recipient obesity and body composition, pulmonary hypertension, alterations in lung microbiome, and autoimmunity to lung collagens. His multidisciplinary lung transplant research focuses on genetics, innate immunity, regulatory T-cells, innate lymphoid cell (ILC) populations in the lung, ischemia reperfusion injury, inflammation, and autoimmunity.



Jennifer Cowger, MD, MS (2020)
St. Vincent's Heart Center of Indiana
Indianapolis, IN, USA
734-546-4911
Jennifercowger@gmail.com

Dr. Jennifer Cowger is the medical director of the Henry Ford Mechanical Circulatory Support Program in Detroit, Michigan. She has a masters in biostatistics & clinical trial design from the University of Michigan and is the chair of the IMACS research committee and is on the DAAP Committee of INTERMACS. She joined the ISHLT board of directors in 2017 and is a liaison for the Education committee.



Teresa De Marco, MD, FACC (2020)
University of California, San Francisco
San Francisco, California, USA
415-476-3117
demarco@medicine.ucsf.edu

Bio coming soon...
Tobias Deuse, MD, PhD (2018)
University of California - San Francisco
San Francisco, CA, USA
Tobias.Deuse@ucsf.edu

Tobias Deuse is Transplant and MCS Surgeon at the University of California San Francisco. He completed his cardiothoracic residency in Munich and Hamburg, and completed a fellowship in Thoracic Transplantation and Mechanical Circulatory Support at Stanford University. His main clinical interests are minimally-invasive lung transplantation and minimally-invasive LVAD implantation. His research focus includes the development of new immunosuppressive/ immunomodulatory agents and alternative forms of administration like inhaled immunosuppression or cell-based immunomodulation. He is also active in the field of pluripotent stem cell research and tissue regeneration.



Howard J. Eisen, MD (2019)
Drexel University College of Medicine
Philadelphia, PA, USA
heisen@drexelmed.edu

Bio coming soon...

Stephan M. Ensminger, MD, DPhil (2020)
Heart and Diabetes Center NRW
Ruhr-University Bochum
Bad Oeynhausen, GERMANY
05731 / 97 1331
sensminger@hdz-nrw.de

Bio coming soon...


Daniel J. Goldstein, MD (2018)
Montefiore Medical Center
Bronx, New York, USA
718-920-2144
dgoldste@montefiore.org

Dr. Daniel J. Goldstein is a Professor at the Albert Einstein College of Medicine and Vice Chairman of the Department of Cardiothoracic Surgery at Montefiore Medical Center in New York where he also serves as the Director of the Mechanical Assistance Program. He is a graduate of the Mount Sinai School of Medicine (1991) and completed his general surgery and cardiothoracic surgery training at Columbia Presbyterian Medical Center in New York in 2000. While clinically active in all aspects of adult cardiothoracic surgery including coronary, valvular and aneurysmal heart disease, his clinical and research interests focus on the surgical management of end stage heart disease including stem cell therapies and pharmacological adjuncts for induction of left ventricular recovery in patients supported with left ventricular assist devices. Dr. Goldstein is an active member of the INTERMACS adverse event committee and has partaken as principal site investigator in multiple industry-based and NIH-supported clinical ventricular assist device trials.


Peter M. Hopkins, FRACP (2018)
The Prince Charles Hospital
Brisbane, AUSTRALIA
61-7-3350-8111
Peter_Hopkins@health.qld.gov.au

Dr Peter Hopkins is the Director of the Queensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. Executive positions are held with the Australian Lung Foundation (PIVOT and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and National Examiners Panel Royal Australian College of Physicians.


Michael G. Petty, PhD, RN, CNS (2018)
University of Minnesota Medical Center
Minneapolis, MN, USA
612-273-5607
mpetty1@fairview.org

Dr. Michael Petty is the Cardiothoracic Clinical Nurse Specialist at the University of Minnesota Medical Center, Minneapolis, MN.  He received his initial nursing degree from St. Mary’s Junior College, Minneapolis, MN, and subsequently obtained a Bachelors Degree in Nursing from the University of the State of New York, and a Masters Degree and PhD in Nursing from the University of Minnesota.  He began his career as a staff nurse in the Surgical ICU at the University of Minnesota Hospital and Clinic, and has held a variety of clinical, administrative, and industry roles in the subsequent years.  Much of his focus and interest during that time has been in the care of patients with cardiovascular disorders requiring medical, surgical, and transplant interventions. He has been an active participant in the Mechanical Circulatory Support community since 1995 including serving as president of the International Consortium of Circulatory Assist Clinicians (ICCAC) in 2013.  His clinical research interests focus on thoracic transplant and family caregivers of MCS patients.


Dirk Van Raemdonck, MD, PhD (2019)
University Hospital Gasthuisberg
Leuven, Belgium
32-16-34-68-23
dirk.vanraemdonck@uz.kuleuven.ac.be

Bio coming soon...


EX-OFFICIO BOARD MEMBERS:


EXECUTIVE DIRECTOR
Amanda W. Rowe (1992 - Present)
ISHLT
14673 Midway Rd., Suite 200
Addison, Texas, 75001
972-490-9495
amanda.rowe@ishlt.org

Bio coming soon...

2017-2018 ISHLT Board of Directors

Members of the 2017-2018 ISHLT Board of Directors convened in April 2017 at the ISHLT Annual Meeting in San Diego, CA.

Text SizeIncrease Font SizeDecrease Font Size